financetom
Business
financetom
/
Business
/
National Bank Doesn't See Latest Canada Government Stimulus Package Impacting Much Central Bank's Policies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
National Bank Doesn't See Latest Canada Government Stimulus Package Impacting Much Central Bank's Policies
Nov 22, 2024 4:11 AM

06:47 AM EST, 11/22/2024 (MT Newswires) -- The government of Canada Thursday unveiled a fresh stimulus package

designed to "give Canadians more money in their pocket" ahead of the

holiday season, noted National Bank of Canada.

These tax breaks are entirely a 2024-25 story, the 'rebate' being a one-time payment and the HST holiday ending Feb. 15, 2025.

The bank said it doesn't expect these new measures to have a

"substantial" impact on monetary policy decisions. After all, this amounts to less than 0.3% of gross domestic product. Worthy of a slight growth upgrade to be sure but unlikely to have a significant or sustained inflation impact.

However, the spending announcement doesn't come in isolation, pointed out National Bank. Stimulus efforts are also underway at the provincial level too, with Ontario readying a similar taxpayer 'rebate'.

Meanwhile, recent inflation data came in stronger than expected at the same as housing market activity accelerated and the unemployment rate stabilized -- at least temporarily.

The bank had argued that the size of the output gap warrants a rapid return to neutral via a 50bsp cut in December but for a central bank putting all its eggs in the data dependence basket, that's become a harder sell.

If the Bank of Canada, like financial markets, viewed the 25bps versus 50bps rate cut debate as a coin toss back in October, recent developments may push it to 25 bps, stated National Bank. But even if easing is more gradual in the near term, the bank isn't fundamentally recasting its Canadian outlook or its forecast of the terminal rate on what amounts to a modest, even if ill-timed spending announcement.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Inspire Veterinary Partners to Effect 1-for-25 Reverse Stock Split
Inspire Veterinary Partners to Effect 1-for-25 Reverse Stock Split
Jan 23, 2025
04:36 AM EST, 01/23/2025 (MT Newswires) -- Inspire Veterinary Partners ( IVP ) said Wednesday that it will effect a 1-for-25 reverse stock split, effective before the opening of trading on Monday. Each 25 shares will automatically be reclassified into one new share and the total number of shares will be reduced to about 1.5 million from 37 million, the...
India sends notices to ride-hailing apps Ola, Uber over 'differential pricing'
India sends notices to ride-hailing apps Ola, Uber over 'differential pricing'
Jan 23, 2025
Jan 23 (Reuters) - An Indian government body has sent notices to ride-hailing firms Ola and Uber ( UBER ) over alleged differential pricing for Android and Apple phones, the country's consumer affairs minister, Pralhad Joshi, said in a post on X on Thursday. ...
Disc Medicine Prices Upsized $225.5 Million Offering
Disc Medicine Prices Upsized $225.5 Million Offering
Jan 23, 2025
04:27 AM EST, 01/23/2025 (MT Newswires) -- Disc Medicine ( IRON ) said late Wednesday it priced its public offering of common stock and pre-funded warrants for gross proceeds of about $225.5 million, upsized from the initial offering of $200 million. The company said it is selling about 3.9 million shares and pre-funded warrants to purchase 181,818 shares. The common...
Zai Lab Says FDA Grants Orphan Drug Designation for ZL-1310
Zai Lab Says FDA Grants Orphan Drug Designation for ZL-1310
Jan 23, 2025
04:31 AM EST, 01/23/2025 (MT Newswires) -- Zai Lab ( ZLAB ) said late Wednesday the US Food and Drug Administration has granted orphan drug designation to ZL-1310 for the treatment of small cell lung cancer following data from an ongoing phase 1a/1b study. ZL-1310 will be eligible for certain development incentives, including tax credits for certain clinical trials and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved